GERN
Geron Corporation
1.91
USD
This page is just a preview of the data found in TrendSpider’s full version
Geron Corporation stock is down 0% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.43% of the previous 27 November’s closed higher than October. In the last 6 Unusual Options Trades, there were 2 PUTs, 4 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 02 Oct 17:15 | 15 Dec, 2023 | 3.00 | 146 | ||
| 09 Oct 19:44 | 17 Jan, 2025 | 3.00 | 1509 | ||
| 09 Oct 19:45 | 15 Mar, 2024 | 1.50 | 311 | ||
| 09 Oct 19:45 | 17 Jan, 2025 | 3.00 | 1509 | ||
| 17 Oct 17:47 | 17 Jan, 2025 | 4.00 | 4693 | ||
| 17 Oct 17:48 | 17 Jan, 2025 | 4.00 | 4693 |
Geron Corporation focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials. The company was incorporated in 1990 and is headquartered in Foster City, California.
